SHZ:002393
Tianjin Lisheng Pharmaceutical Co.,Ltd. · SHZ · Healthcare · CNY · FY for 2025
Figures on this page computed 2026-11-08 00:05 UTC
Last close
n/aCNY
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
8.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
30.0%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
29.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
2.7%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- computed
6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.14x
Its own average over 10 years, 1.23B.
- Profit2.33x
Its own average over 10 years, 179.5M.
- Free cash flow3.04x
Its own average over 10 years, 136.3M.
- Debt2.70x
Its own average over 10 years, 64.3M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 3.04 times.
A find tonight
The earnings in its last filed year are 12.3 percent of what the whole company costs, trades at 0.73 times the book value it last filed, and scores 7 of Piotroski's nine tests on its last filings.
- Value
- 78
- Cheap
- 97
- Sound
- 59
- Unwatched
- 79
What stands out
- Safety: scores 7 of Piotroski's nine tests on its last filings, which is better than 82 percent of the companies we rank in Shenzhen Stock Exchange.
- Price: the earnings in its last filed year are 12.3 percent of what the whole company costs, which is better than 99 percent of the companies we rank in Shenzhen Stock Exchange.
What could make it a trap
- None of the tests we hold fired against it: we checked Altman's Z, the five-year net margin trend, share count, Beneish's M, interest cover and the last year of price. That is the absence of a flag we look for and not a clean bill of health.
Why it is cheap
Except where said otherwise: Computed from the filing for 2025
Earnings yield12.3%
Filed net income for the last annual period, over market value
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-04
- Reported in
- CNY
- Computed from the FY for 2025
- Market data, 2026-11-04
Free cash flow yield12.2%
Filed operating cash flow less capital expenditure, over market value
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-04
- Reported in
- CNY
- Computed from the FY for 2025
- Market data, 2026-11-04
Price to book0.7x
Market value over filed total equity
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-04
- Reported in
- CNY
- Computed from the FY for 2025
- Market data, 2026-11-04
Cash and equivalents against market value45.4%
Filed cash and equivalents, over market value
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-04
- Reported in
- CNY
- Computed from the FY for 2025
- Market data, 2026-11-04
Altman Z-Score3.81Computed from the FY for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Piotroski F-Score7.00Computed from the FY for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Earnings quality (Sloan accruals)1.01Computed from the FY for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Consecutive profitable filed years10Computed from the FY for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Last close: Market data, 2026-11-04
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 121.6 | 101.0 | 99.5 |
| 2018-12-31 | 177.6 | 160.0 | 99.8 |
| 2019-12-31 | 190.7 | 162.7 | 99.5 |
| 2020-12-31 | 134.7 | 7.5 | 93.9 |
| 2021-12-31 | 128.9 | 105.6 | 99.3 |
| 2022-12-31 | 135.4 | 81.0 | 100.0 |
| 2023-12-31 | 136.2 | 313.0 | 100.6 |
| 2024-12-31 | 157.8 | 159.6 | 99.8 |
| 2025-12-31 | 164.5 | 361.9 | 100.5 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Figures behind the shape
Growth
4.1%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate4.1%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- computed
Five-year EPS growth rate114.5%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- computed
One-year change in net income126.7%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- computed
Returns on capital
9.0%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity9.0%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets7.5%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
100.0%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin100.0%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin33.8%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin30.0%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin29.8%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
8.0xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings8.0x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- computed
- Computed from the filing for 2025
Price to book0.7x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio2.4x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
4.37safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio4.37
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage163.9x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score3.77
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
2.7%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield2.7%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- computed
Payout ratio21.4%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio4.6x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CNY
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.